Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2025-12-25 @ 1:14 AM
NCT ID: NCT05099393
Eligibility Criteria: Inclusion Criteria: * Male or female aged≥ 18 years * Signed informed consent * Body mass index: * 25 kg/m² ≥ BMI ≥ 18,5 kg/m² (lean subjects) * \>30 kg/m2, with waist-to-hip ratio \>0.9 (subjects with obesity) * Person who is affiliated to a social security scheme or who is a beneficiary of such a scheme Exclusion Criteria: * Any chronic disease with vascular impact (including type 2 diabetes) * Active tobacco use (any quantity) * Participant involved in another interventional clinical study * History of hypersensitivity reaction to products used * The persons mentioned in articles L1121-5 to L1121-9 of the public health code may not be included in this research (Pregnancy or Lactation ; Females with childbearing potential, defined as a premenopausal female and not using an effective form of birth control. (Effective birth control methods include: oral, implant or patch hormone contraception; intrauterine device; abstinence and outercourse; tubal ligation; vasectomy.) ; Person deprived of liberty by judicial order ; Person under guardianship or curatorship ; Minors ; Adults who are incapable or unable to give their consent ; Cross-over situations) * Subject who would receive more than 4500 euros in compensation due to his or her participation in other research involving the human person in the 12 months preceding this study
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 100 Years
Study: NCT05099393
Study Brief:
Protocol Section: NCT05099393